Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-24 @ 4:49 PM
NCT ID:
NCT05044650
Eligibility Criteria:
Inclusion Criteria:
* Male or female, aged from 18-65, Vietnamese nationality
* Participants diagnosed with Positive result of SARS-CoV-2 using real time RT-PCR test, Ct value \<30 (equivalent to viral load \> 3log)
* Voluntary participation in the study by signing an informed consent
* Ability to adhere to treatment according to the investigator's assessment
Exclusion Criteria:
* Symptoms of severe upper and lower respiratory tract infections such as dyspnea, SpO2\<93%.
* Acute reduction of ventilation function of respiratory apparatus and/or respiration function of the lung in any of the following three groups:
* Respiratory distress due to hypoxemia with PaO2 less than 60mmHg when breathing room air.
* Respiratory distress due to hypercapnia with PaCO2 above 50mmHg
* Mixed respiratory distress accompanied by both a decrease in PaO2 and an increase in PaCO2
* Allergy/intolerance to any component of the study drug.
* Inability to administer medicine.
* Severe pneumonia as assessed by the investigator.
* Inability to comply with study procedures or to ensure compliance with study drug administration as assessed by investigators.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT05044650
Study Brief:
Protocol Section:
NCT05044650